FDA Clears Roche’s CSF Biomarkers for Alzheimer’s Disease
Roche has obtained FDA clearance for Alzheimer’s tests in the U.S. that include two ratios comprising three assays. The Elecsys® beta-Amyloid (1-42)(Abeta42) protein , Elecsys® Phospho-Tau (181P) CSF , total-Tau CSF (tTau)can aid in the diagnosis of Alzheimer’s disease by measuring levels of beta-amyloid and tau protein. The Abeta42 and pTau181 assays are currently available, while the total … Read more